Sigma Healthcare Limited (F:S5YA) — Market Cap & Net Worth
Market Cap & Net Worth: Sigma Healthcare Limited (S5YA)
Sigma Healthcare Limited (F:S5YA) has a market capitalization of $19.74 Billion (€16.88 Billion) as of June 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #1324 globally and #290 in its home market, demonstrating a -4.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sigma Healthcare Limited's stock price €1.67 by its total outstanding shares 11543702836 (11.54 Billion). Review Sigma Healthcare Limited debt and liabilities to assess the company's total debt and financial obligations.
Sigma Healthcare Limited Market Cap History: 2015 to 2026
Sigma Healthcare Limited's market capitalization history from 2015 to 2026. Data shows growth from $4.61 Billion to $22.54 Billion (17.38% CAGR).
Sigma Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sigma Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.71x
Sigma Healthcare Limited's market cap is 3.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
42.02x
Sigma Healthcare Limited's market cap is 42.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $6.49 Billion | $4.42 Billion | $53.18 Million | 1.47x | 121.96x |
| 2018 | $3.69 Billion | $4.13 Billion | $55.06 Million | 0.89x | 67.06x |
| 2019 | $4.75 Billion | $4.02 Billion | $36.52 Million | 1.18x | 129.97x |
| 2020 | $4.39 Billion | $3.24 Billion | -$12.33 Million | 1.35x | N/A |
| 2021 | $3.70 Billion | $3.40 Billion | $59.76 Million | 1.09x | 61.85x |
| 2022 | $4.63 Billion | $3.45 Billion | -$7.24 Million | 1.34x | N/A |
| 2023 | $8.13 Billion | $3.73 Billion | $1.81 Million | 2.18x | 4489.16x |
| 2024 | $21.19 Billion | $3.38 Billion | $4.51 Million | 6.28x | 4699.14x |
| 2025 | $22.27 Billion | $6.00 Billion | $529.91 Million | 3.71x | 42.02x |
Competitor Companies of S5YA by Market Capitalization
Companies near Sigma Healthcare Limited in the global market cap rankings as of June 17, 2026.
Key companies related to Sigma Healthcare Limited by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #271 globally with a market cap of $94.41 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #538 globally with a market cap of $50.53 Billion USD.
- Henry Schein Inc (NASDAQ:HSIC): Ranked #2698 globally with a market cap of $7.86 Billion USD.
- Shanghai Pharmaceuticals Holding Co Ltd (SHG:601607): Ranked #3031 globally with a market cap of $6.59 Billion USD ( CN¥45.05 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | McKesson Corporation | NYSE:MCK | $94.41 Billion | $785.43 |
| #538 | Cencora Inc. | NYSE:COR | $50.53 Billion | $281.46 |
| #2698 | Henry Schein Inc | NASDAQ:HSIC | $7.86 Billion | $81.21 |
| #3031 | Shanghai Pharmaceuticals Holding Co Ltd | SHG:601607 | $6.59 Billion | CN¥16.15 |
Sigma Healthcare Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Sigma Healthcare Limited's market cap moved from $4.61 Billion to $ 22.54 Billion, with a yearly change of 17.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €22.54 Billion | +1.21% |
| 2025 | €22.27 Billion | +5.10% |
| 2024 | €21.19 Billion | +160.62% |
| 2023 | €8.13 Billion | +75.52% |
| 2022 | €4.63 Billion | +25.30% |
| 2021 | €3.70 Billion | -15.80% |
| 2020 | €4.39 Billion | -7.51% |
| 2019 | €4.75 Billion | +28.55% |
| 2018 | €3.69 Billion | -43.07% |
| 2017 | €6.49 Billion | -17.90% |
| 2016 | €7.90 Billion | +71.42% |
| 2015 | €4.61 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Sigma Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.74 Billion USD |
| MoneyControl | $19.74 Billion USD |
| MarketWatch | $19.74 Billion USD |
| marketcap.company | $19.74 Billion USD |
| Reuters | $19.74 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemi… Read more